Patient preferences for care for metabolic dysfunction associated steatotic liver disease (MASLD): 

Let's move towards patient-centred care

Metabolic dysfunction associated steatotic liver disease (MASLD) 

• MASLD (fatty liver disease) occurs when there is excess fat in the liver

• MASLD affects 1 in 3 men & 1 in 4 women in UK

• The main causes of MASLD are obesity & type 2 diabetes

• While there is no drug treatment for MASLD, weight loss can reverse disease progression

Research participants - we want to hear from you

We are looking for people to attend an interview, or small discussion group to ask people about their preferences regarding care for fatty liver disease

• The discussion can take place online / in person / telephone depending on your preference 

• The discussion will take between 30 mins to 2 hours

• All participants enrolled will be paid £25/hr for their time via a amazon voucher

• Findings will be used to design a patient-centred' model of care for people with fatty liver disease

Please do not worry if you do not know anything about fatty liver disease, no prior knowledge is required!

Am I eligible to take part?


We would like to speak to anyone who is over 18 years old and either:


1. Is living with being overweight or type 2 diabetes

OR

2. Has a diagnosis of fatty liver disese (MASLD) from your GP or the hospital


* Excluding people who drink high levels of alcohol

Research Team

Dr Theresa Hydes, University of Liverpool (Study lead)

Katie Williams, University of Liverpool (Research Assistant)

Dr Louise Roper, University of Liverpool

Dr Helen Jarvis, Newcastle University

Professor Deirdre Lane, University of Liverpool

Professor Dan Cuthbertson, University of Liverpool

Dr Cyril Sieberhagen, Liverpool University Hospitals NHS Foundation Trust 

Dr Mike Merriman, Liverpool University Hospitals NHS Foundation Trust


Get in touch

If you are interested in taking part please email us with your name and we will contact you back. Thank you!

   nafldpp@liverpool.ac.uk

Participating sites: Primary care

Millbrook Medical Centre (Liverpool), Mike Merriman

Solent Health (Southampton), Tina Reinson

Bellingham Practice (Northumberland), Helen Jarvis

Llandaff and Pentyrch surgery (Wales), Sophie Davies

Ashgrove Surgery (Wales), Tom Hodges-Hoyland

Marine Lake Medical Practice (Wirral), James Perry

Ashfields Primary Care Centre (Cheshire), Neil Paul

Fernhead Cross Medical Centre (Warrington), Dawn Tragen

The Eric Moore Partnership (Warrington), Dr Mariscal

Carn to Coast Health Centres (Cornwall), John Madine

The Atlantic Medical Group (Cornwall), John Ryan

Pathfields Medical Group (Plymouth), James Boorer

Little Harwood Health Centre (Blackburn), Javed Shaikh

Garswood Surgery (Wigan), Nicola Horrigan

Station House Surgery (Cumbria), David Cowling

Fulwood Green Medical Centre (Liverpool), Jamie Hampson

Princess Street Practice (London), Dr Osonuga

Decima Street Surgery (London), Dr Osonuga

East of England Priamry Care Practices are also promoting this study

Participating sites: Secondary care

Aintree University Hospital, Theresa Hydes/Cyril Sieberhagen

Royal Liverpool University Hospital, Omar Elshaarawy

Barts NHS Foundation Trust, Will Alazawi

Imperial NHS Foundation Trust, Pinelopi Manasou

Southampton NHS Foundation Trust, Ryan Buchanan

Swansea NHS Foundation Trust, Jag Nagaraj

University Hospitals Plymouth NHS Foundation Trust, Charlotte Williams

Update 30/8/24: Recruitment is now complete for this study. The research team have spoken to 33 people with or at risk of fatty liver disease. A full study report will be published at the end of the year. Thank you to all those who took part.

Create your website for free!